Cytokine Augmentation Reverses Transplant Recipient Neutrophil Dysfunction Against the Human Fungal Pathogen Candida

Nicolas Barros1, Natalie Alexander2, Adam Viens2

  • 1Division of Infectious Diseases, Indiana University Health, Indianapolis, Indiana, USA.

Abstract

Insights

Neutrophils from transplant patients show reduced anti-fungal activity, increasing infection risk. Cytokine therapy can partially restore neutrophil function, improving outcomes for solid organ and stem cell transplant recipients.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Infectious Diseases

Background:

  • Solid organ transplant (SOT) and stem cell transplant (SCT) recipients face a heightened risk of invasive fungal disease.
  • This increased susceptibility occurs even when neutrophil counts are within normal ranges.

Purpose of the Study:

  • To investigate neutrophil anti-Candida activity in SOT and SCT recipients.
  • To compare the fungicidal capacity and hyphal growth control of neutrophils from transplant patients versus healthy controls.

Main Methods:

  • Neutrophils from 21 SOT, 19 SCT recipients, and 23 healthy controls (HC) were coincubated with Candida albicans.
  • Assessed were the percentage of fungal killing and neutrophil swarming responses.
  • Serum inhibitory effects and the impact of cytokine augmentation (G-CSF, GM-CSF) were evaluated.

Main Results:

  • Neutrophils from both SOT and SCT recipients exhibited significantly decreased fungicidal capacity compared to HC.
  • Transplant recipients' neutrophils showed diminished ability to control Candida hyphal growth.
  • Serum from SCT recipients, but not SOT recipients, inhibited healthy neutrophil anti-Candida activity.
  • Granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) partially restored neutrophil function.

Conclusions:

  • Neutrophils from SOT and SCT recipients display impaired anti-Candida responses despite normal counts.
  • Both intrinsic neutrophil defects and extrinsic serum factors contribute to this dysfunction.
  • Cytokine therapy offers a potential strategy to partially reverse neutrophil dysfunction in transplant patients.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
80.2K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
723
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
154
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.1K